New Publication Broadens the Potential of DiviTum TKa in Immuno-Oncology

Biovica, a company specializing in blood-based cancer monitoring, today announced that new results involving DiviTum TKa have been published in the peer-reviewed journal Clinical Cancer Research.The study evaluated DiviTum TKa in patients with …